PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 51 filers reported holding PSYCHEMEDICS CORP in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $46,000 | -99.9% | 9,000 | 0.0% | 0.04% | +15.4% |
| Q2 2020 | $49,500,000 | -41.6% | 9,000 | -35.7% | 0.04% | -53.0% |
| Q1 2020 | $84,700,000 | -72.1% | 14,000 | -11.4% | 0.08% | -67.1% |
| Q4 2019 | $303,992,000 | +118.1% | 15,800 | +3.3% | 0.25% | +147.1% |
| Q3 2019 | $139,383,000 | -9.7% | 15,300 | 0.0% | 0.10% | -19.0% |
| Q2 2019 | $154,377,000 | -28.1% | 15,300 | 0.0% | 0.13% | -25.0% |
| Q1 2019 | $214,659,000 | -14.4% | 15,300 | -3.2% | 0.17% | -20.0% |
| Q4 2018 | $250,746,000 | -15.6% | 15,800 | 0.0% | 0.21% | +1.0% |
| Q3 2018 | $297,198,000 | -2.2% | 15,800 | 0.0% | 0.21% | -8.4% |
| Q2 2018 | $303,992,000 | -9.9% | 15,800 | 0.0% | 0.23% | -8.1% |
| Q1 2018 | $337,488,000 | +5.9% | 15,800 | +1.9% | 0.25% | +1.6% |
| Q4 2017 | $318,680,000 | +11.6% | 15,500 | 0.0% | 0.24% | +6.1% |
| Q3 2017 | $285,665,000 | -26.1% | 15,500 | 0.0% | 0.23% | -21.0% |
| Q2 2017 | $386,725,000 | – | 15,500 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tieton Capital Management, LLC | 256,359 | $4,725,000 | 4.06% |
| Moors & Cabot, Inc. | 337,060 | $6,218,000 | 0.90% |
| CARL DOMINO INC | 11,236 | $207,000 | 0.25% |
| Gs Investments, Inc. | 15,500 | $285,665,000 | 0.23% |
| Ativo Capital Management LLC | 46,327 | $854,000 | 0.23% |
| North Star Investment Management Corp. | 78,271 | $1,443,000 | 0.18% |
| RBF Capital, LLC | 78,495 | $1,447,000 | 0.18% |
| Uniplan Investment Counsel, Inc. | 191,822 | $3,535,000 | 0.15% |
| QUANTUM CAPITAL MANAGEMENT | 30,669 | $565,000 | 0.13% |
| CRAWFORD INVESTMENT COUNSEL INC | 205,493 | $3,787,000 | 0.12% |